Cargando…
JMJD3 suppresses tumor progression in oral tongue squamous cell carcinoma patients receiving surgical resection
BACKGROUND: Jumonji domain-containing-3 (JMJD3) is reported to be a histone H3 lysine 27 (H3K27) demethylase and a tumor suppressor gene. The present study designed to investigate the crucial role of JMJD3 in oral tongue squamous cell carcinoma (OTSCC) patients who received surgical resection. METHO...
Autores principales: | Chen, Yen-Hao, Chen, Chang-Han, Chien, Chih-Yen, Su, Yan-Ye, Luo, Sheng-Dean, Li, Shau-Hsuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288160/ https://www.ncbi.nlm.nih.gov/pubmed/35855897 http://dx.doi.org/10.7717/peerj.13759 |
Ejemplares similares
-
Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study
por: Chen, Yen-Hao, et al.
Publicado: (2021) -
Nox4 Overexpression as a Poor Prognostic Factor in Patients with Oral Tongue Squamous Cell Carcinoma Receiving Surgical Resection
por: Chen, Yen-Hao, et al.
Publicado: (2018) -
Mitochondrial assembly receptor expression is an independent prognosticator for patients with oral tongue squamous cell carcinoma
por: Su, Yan-Ye, et al.
Publicado: (2017) -
Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma
por: Li, Shau-Hsuan, et al.
Publicado: (2017) -
Serum Levels of Stromal Cell-Derived Factor-1α and Vascular Endothelial Growth Factor Predict Clinical Outcomes in Head and Neck Squamous Cell Carcinoma Patients Receiving TPF Induction Chemotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2022)